{"id":"https://openalex.org/W2911380652","doi":"https://doi.org/10.1016/j.euroneuro.2019.01.044","title":"P.2.13 High reproducibility across sites in a pre-clinical study through a coordinated behavioural and pharmacological protocol","display_name":"P.2.13 High reproducibility across sites in a pre-clinical study through a coordinated behavioural and pharmacological protocol","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2911380652","doi":"https://doi.org/10.1016/j.euroneuro.2019.01.044","mag":"2911380652"},"language":"en","primary_location":{"id":"doi:10.1016/j.euroneuro.2019.01.044","doi":"https://doi.org/10.1016/j.euroneuro.2019.01.044","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2019.01.044","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://research.rug.nl/en/publications/8892e710-ec4c-446c-a233-0e2e99c9ee2e","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101047691","display_name":"M. Arroyo Araujo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"M. Arroyo Araujo","raw_affiliation_strings":["Groningen institute for evolutionary life sciences, Neurobiology, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groningen institute for evolutionary life sciences, Neurobiology, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022552007","display_name":"Radka Graf","orcid":"https://orcid.org/0000-0001-8755-6172","observed_orcids":["https://orcid.org/0000-0001-8755-6172"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Graf","raw_affiliation_strings":["Pfizer Inc, Neuroscience, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Neuroscience, Cambridge, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020940299","display_name":"Martine Maco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M. Maco","raw_affiliation_strings":["Roche Pharmaceuticals, Neuroscience, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceuticals, Neuroscience, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042344972","display_name":"Elsbeth van Dam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098600","display_name":"Noldus Information Technology","ror":"https://ror.org/00tzgse53","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210098600"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"E. Van Dam","raw_affiliation_strings":["Noldus Information Technologies, n/a, Wageningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Noldus Information Technologies, n/a, Wageningen, The Netherlands","institution_ids":["https://openalex.org/I4210098600"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088163628","display_name":"Esther Schenker","orcid":"https://orcid.org/0000-0002-6491-8721","observed_orcids":["https://orcid.org/0000-0002-6491-8721"]},"institutions":[{"id":"https://openalex.org/I4210135308","display_name":"Servier (France)","ror":"https://ror.org/034e7c066","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210135308"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Schenker","raw_affiliation_strings":["Servier Laboratories, Neuroscience drug discovery unit, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Laboratories, Neuroscience drug discovery unit, Paris, France","institution_ids":["https://openalex.org/I4210135308"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084652173","display_name":"Pim Drinkenburg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Drinkenburg","raw_affiliation_strings":["Janssen, Neurosciences, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen, Neurosciences, Leuven, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036504629","display_name":"Bastijn Koopmans","orcid":"https://orcid.org/0000-0001-8638-9798","observed_orcids":["https://orcid.org/0000-0001-8638-9798"]},"institutions":[{"id":"https://openalex.org/I4210087794","display_name":"Sylics (Netherlands)","ror":"https://ror.org/003eebv14","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210087794"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"B. Koopmans","raw_affiliation_strings":["Sylics Bioinformatics, n/a, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sylics Bioinformatics, n/a, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210087794"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050432559","display_name":"Sietse F. de Boer","orcid":"https://orcid.org/0000-0003-1418-2792","observed_orcids":["https://orcid.org/0000-0003-1418-2792"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"S. De Boer","raw_affiliation_strings":["Groningen institute for evolutionary life sciences, Neurobiology, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groningen institute for evolutionary life sciences, Neurobiology, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079240846","display_name":"Michaela Cullum\u2010Doyle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Cullum-Doyle","raw_affiliation_strings":["Pfizer Inc, Neuroscience, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Neuroscience, Cambridge, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053766937","display_name":"Lucas P. J. J. Noldus","orcid":"https://orcid.org/0000-0003-3966-5598","observed_orcids":["https://orcid.org/0000-0003-3966-5598"]},"institutions":[{"id":"https://openalex.org/I4210098600","display_name":"Noldus Information Technology","ror":"https://ror.org/00tzgse53","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210098600"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"L. Noldus","raw_affiliation_strings":["Noldus Information Technologies, n/a, Wageningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Noldus Information Technologies, n/a, Wageningen, The Netherlands","institution_ids":["https://openalex.org/I4210098600"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018627313","display_name":"Maarten Loos","orcid":"https://orcid.org/0000-0003-1629-2928","observed_orcids":["https://orcid.org/0000-0003-1629-2928"]},"institutions":[{"id":"https://openalex.org/I4210087794","display_name":"Sylics (Netherlands)","ror":"https://ror.org/003eebv14","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210087794"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. Loos","raw_affiliation_strings":["Sylics Bioinformatics, n/a, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sylics Bioinformatics, n/a, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210087794"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038126755","display_name":"Wil van Dommelen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098600","display_name":"Noldus Information Technology","ror":"https://ror.org/00tzgse53","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210098600"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W. Van Dommelen","raw_affiliation_strings":["Noldus Information Technologies, n/a, Wageningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Noldus Information Technologies, n/a, Wageningen, The Netherlands","institution_ids":["https://openalex.org/I4210098600"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051611586","display_name":"Will P. J. M. Spooren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Spooren","raw_affiliation_strings":["Pfizer Inc, Neuroscience, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Neuroscience, Cambridge, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069173699","display_name":"Barbara Biemans","orcid":"https://orcid.org/0000-0002-2667-6821","observed_orcids":["https://orcid.org/0000-0002-2667-6821"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"B. Biemans","raw_affiliation_strings":["Roche Pharmaceuticals, Neuroscience, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceuticals, Neuroscience, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071469063","display_name":"Derek L. Buhl","orcid":"https://orcid.org/0000-0003-4433-7150","observed_orcids":["https://orcid.org/0000-0003-4433-7150"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.L. Buhl","raw_affiliation_strings":["Pfizer Inc, Neuroscience, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Neuroscience, Cambridge, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056480595","display_name":"Martien J. Kas","orcid":"https://orcid.org/0000-0002-4471-8618","observed_orcids":["https://orcid.org/0000-0002-4471-8618"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M.J. Kas","raw_affiliation_strings":["Groningen institute for evolutionary life sciences, Neurobiology, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groningen institute for evolutionary life sciences, Neurobiology, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5101047691"],"corresponding_institution_ids":["https://openalex.org/I169381384"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.1313,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.45426316,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"29","issue":null,"first_page":"S664","last_page":"S664"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10982","display_name":"Motor Control and Adaptation","score":0.47530001401901245,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10982","display_name":"Motor Control and Adaptation","score":0.47530001401901245,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.09480000287294388,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.06870000064373016,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gait-analysis","display_name":"gait analysis","score":0.8949999809265137},{"id":"https://openalex.org/keywords/catwalk","display_name":"catwalk","score":0.8119999766349792},{"id":"https://openalex.org/keywords/motor-coordination","display_name":"motor coordination","score":0.8539999723434448},{"id":"https://openalex.org/keywords/ataxia","display_name":"ataxia","score":0.9340000152587891},{"id":"https://openalex.org/keywords/enriched-housing","display_name":"enriched housing","score":0.7459999918937683},{"id":"https://openalex.org/keywords/ethanol-induced-ataxia","display_name":"ethanol-induced ataxia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/spinocerebellar-ataxia-type-17","display_name":"spinocerebellar ataxia type 17","score":0.8960000276565552},{"id":"https://openalex.org/keywords/rat-model","display_name":"rat model","score":0.8149999976158142},{"id":"https://openalex.org/keywords/training-adaptation","display_name":"training effects","score":0.8880000114440918},{"id":"https://openalex.org/keywords/stride-length","display_name":"stride length","score":0.5210000276565552},{"id":"https://openalex.org/keywords/walking-speed","display_name":"walking speed","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2780906641","wikidata":"https://www.wikidata.org/wiki/Q213373","display_name":"Ataxia","level":2,"score":0.7907000184059143},{"id":"https://openalex.org/C113062710","wikidata":"https://www.wikidata.org/wiki/Q2463100","display_name":"Motor coordination","level":2,"score":0.7365153431892395},{"id":"https://openalex.org/C151800584","wikidata":"https://www.wikidata.org/wiki/Q2370000","display_name":"Gait","level":2,"score":0.7159137725830078},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.6397024393081665},{"id":"https://openalex.org/C173906292","wikidata":"https://www.wikidata.org/wiki/Q1493441","display_name":"Gait analysis","level":3,"score":0.5538974404335022},{"id":"https://openalex.org/C2778334475","wikidata":"https://www.wikidata.org/wiki/Q1415275","display_name":"Spinal cord injury","level":3,"score":0.4428398013114929},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37631598114967346},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3611084222793579},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3247325122356415},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2998761236667633},{"id":"https://openalex.org/C2780775167","wikidata":"https://www.wikidata.org/wiki/Q9606","display_name":"Spinal cord","level":2,"score":0.2501329779624939}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.euroneuro.2019.01.044","doi":"https://doi.org/10.1016/j.euroneuro.2019.01.044","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2019.01.044","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/8892e710-ec4c-446c-a233-0e2e99c9ee2e","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/8892e710-ec4c-446c-a233-0e2e99c9ee2e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Neuropsychopharmacology, 29, S664 - S664. ELSEVIER SCIENCE BV","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:rug:oai:pure.rug.nl:publications/8892e710-ec4c-446c-a233-0e2e99c9ee2e","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/8892e710-ec4c-446c-a233-0e2e99c9ee2e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Neuropsychopharmacology, 29, S664 - S664. ELSEVIER SCIENCE BV","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W585341442","https://openalex.org/W1488755133","https://openalex.org/W2048060485","https://openalex.org/W2809176595","https://openalex.org/W2952728789"],"related_works":["https://openalex.org/W2190408341","https://openalex.org/W4379648798","https://openalex.org/W4406202923","https://openalex.org/W2752762029","https://openalex.org/W2002120184","https://openalex.org/W7097118602","https://openalex.org/W2040686838","https://openalex.org/W2599293623","https://openalex.org/W6889991229","https://openalex.org/W2003203844"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2019-02-21T00:00:00"}